Home / Stocks / HEPA

HEPA insider trading

Hepion Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
9
Bought · 24 mo
$1.2M
Buys · last 90 days
5 · $825k
Most recent buy
2026-08-12

Cluster buy detected

5 insiders bought HEPA within a short window (2026-08-03), $825k in total — cluster score 55/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-12Appajosyula Sireeshcluster
Chief Operating Officer
Bought2,000,000$0.05$100k
2026-08-12LoPriore Vincent Scluster
Executive Chairman
Bought10,000,000$0.05$500k
2026-08-12Purcell Michael J.cluster
Director
Bought2,000,000$0.05$100k
2026-08-12Stetz Gary S.cluster
Interim CEO
Bought2,000,000$0.05$100k
2026-08-12Stetz Gary S. IIcluster
Director
Bought500,000$0.05$25k
2026-04-27Purcell Michael J.cluster
Director
Bought1,250,000$0.04$50k
2026-04-27LoPriore Vincent Scluster
Executive Chairman
Bought6,250,000$0.04$250k
2026-04-27Appajosyula Sireeshcluster
Director
Bought1,250,000$0.04$50k
2026-04-27Stetz Gary S.cluster
Interim CEO
Bought1,250,000$0.04$50k

Most active insider buyers

InsiderRoleBuysTotal bought
LoPriore Vincent SExecutive Chairman2$750k
Appajosyula SireeshChief Operating Officer2$150k
Purcell Michael J.Director2$150k
Stetz Gary S.Interim CEO2$150k
Stetz Gary S. IIDirector1$25k

See HEPA on the chart

Every insider buy and sell for HEPA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.